179 related articles for article (PubMed ID: 18044749)
1. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives.
Ward MR; Stewart DJ; Kutryk MJ
Catheter Cardiovasc Interv; 2007 Dec; 70(7):983-98. PubMed ID: 18044749
[TBL] [Abstract][Full Text] [Related]
2. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
Marsboom G; Janssens S
Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
[TBL] [Abstract][Full Text] [Related]
3. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
Kawamoto A; Asahara T
Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
[TBL] [Abstract][Full Text] [Related]
4. Potential use of endothelial progenitor cells for regeneration of the vasculature.
Yamahara K; Itoh H
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668
[TBL] [Abstract][Full Text] [Related]
5. Comparison of various niches for endothelial progenitor cell therapy on ischemic myocardial repair: coexistence of host collateralization and Akt-mediated angiogenesis produces a superior microenvironment.
Zhang S; Zhao L; Shen L; Xu D; Huang B; Wang Q; Lin J; Zou Y; Ge J
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):910-23. PubMed ID: 22328781
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases.
Hung HS; Shyu WC; Tsai CH; Hsu SH; Lin SZ
Cell Transplant; 2009; 18(9):1003-12. PubMed ID: 19650968
[TBL] [Abstract][Full Text] [Related]
7. Additive effects of endothelial progenitor cells combined with ACE inhibition and beta-blockade on left ventricular function following acute myocardial infarction.
Boyle AJ; Schuster M; Witkowski P; Xiang G; Seki T; Way K; Itescu S
J Renin Angiotensin Aldosterone Syst; 2005 Mar; 6(1):33-7. PubMed ID: 16088849
[TBL] [Abstract][Full Text] [Related]
8. Endothelial progenitor cells in pulmonary arterial hypertension.
Diller GP; Thum T; Wilkins MR; Wharton J
Trends Cardiovasc Med; 2010 Jan; 20(1):22-9. PubMed ID: 20685574
[TBL] [Abstract][Full Text] [Related]
9. An update on therapeutic angiogenesis for peripheral vascular disease.
Pacilli A; Faggioli G; Stella A; Pasquinelli G
Ann Vasc Surg; 2010 Feb; 24(2):258-68. PubMed ID: 19467829
[TBL] [Abstract][Full Text] [Related]
10. Tissue engineering of angiogenesis with autologous endothelial progenitor cells.
Zisch AH
Curr Opin Biotechnol; 2004 Oct; 15(5):424-9. PubMed ID: 15464372
[TBL] [Abstract][Full Text] [Related]
11. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.
Devanesan AJ; Laughlan KA; Girn HR; Homer-Vanniasinkam S
Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):475-81. PubMed ID: 19560945
[TBL] [Abstract][Full Text] [Related]
12. Endothelial progenitor cells as therapeutic vectors in cardiovascular disorders: from experimental models to human trials.
Ben-Shoshan J; George J
Pharmacol Ther; 2007 Jul; 115(1):25-36. PubMed ID: 17574679
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial.
Wang XX; Zhang FR; Shang YP; Zhu JH; Xie XD; Tao QM; Zhu JH; Chen JZ
J Am Coll Cardiol; 2007 Apr; 49(14):1566-71. PubMed ID: 17418297
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
[TBL] [Abstract][Full Text] [Related]
15. Endothelial progenitor cells and cardiovascular cell-based therapies.
Mund JA; Ingram DA; Yoder MC; Case J
Cytotherapy; 2009; 11(2):103-13. PubMed ID: 19241233
[TBL] [Abstract][Full Text] [Related]
16. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats.
Song MB; Yu XJ; Zhu GX; Chen JF; Zhao G; Huang L
Vascul Pharmacol; 2009; 51(2-3):205-13. PubMed ID: 19577663
[TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats.
Yip HK; Chang LT; Sun CK; Sheu JJ; Chiang CH; Youssef AA; Lee FY; Wu CJ; Fu M
Crit Care Med; 2008 Mar; 36(3):873-80. PubMed ID: 18431275
[TBL] [Abstract][Full Text] [Related]
18. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.
Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T
Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148
[TBL] [Abstract][Full Text] [Related]
19. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation.
Usami K; Mizuno H; Okada K; Narita Y; Aoki M; Kondo T; Mizuno D; Mase J; Nishiguchi H; Kagami H; Ueda M
J Biomed Mater Res A; 2009 Sep; 90(3):730-41. PubMed ID: 18570318
[TBL] [Abstract][Full Text] [Related]
20. Cell therapy in peripheral arterial disease.
Al Mheid I; Quyyumi AA
Angiology; 2008 Dec-2009 Jan; 59(6):705-16. PubMed ID: 18818233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
